Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-10 · accession 0001628280-24-023258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-14 | 2024-05-10 | AMRX | Autor Deborah M. | Dir | M - OptEx | — | +76.5K | 131.4K | +139% | — |
| D | 2024-05-14 | 2024-05-10 | AMRX | Autor Deborah M. | Dir | M - OptEx | $0.00 | -76.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-10 | M | A | 76,453 | — | 131,402 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2024-05-10 | M | D | 76,453 | $0.00 | 0 | D | — · — to — | 76,453 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024. |